BioLine Rx (STU:YP2) Goodwill-to-Asset: 0.00 (As of Jun. 2026)

BioLine Rx  (STU:YP2) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.

BioLine Rx Goodwill-to-Asset Related Terms

The historical data trend for BioLine Rx's Goodwill-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioLine Rx Goodwill-to-Asset Chart

BioLine Rx Annual Data
	Trend	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24	Dec25
Goodwill-to-Asset		Get a 7-Day Free Trial					0.00	0.00	0.00	0.00	0.00

BioLine Rx Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
Goodwill-to-Asset	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

STU:YP2 vs VRTX, REGN, MRNA: Goodwill-to-Asset Comparison

For the Biotechnology subindustry, BioLine Rx's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioLine Rx Goodwill-to-Asset vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioLine Rx's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where BioLine Rx's Goodwill-to-Asset falls into.

BioLine Rx Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

BioLine Rx's Goodwill to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

BioLine Rx's Goodwill to Asset Ratio for the quarter that ended in Jun. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioLine Rx Business Description